Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds

被引:50
作者
Pelekis, M
Gephart, LA
Lerman, SE
机构
[1] ExxonMobil Biomed Sci Inc, Toxicol & Environm Sci Div, Annandale, NJ 08801 USA
[2] ExxonMobil Biomed Sci Inc, Occupat & Publ Hlth Div, Annandale, NJ 08801 USA
关键词
D O I
10.1006/rtph.2000.1436
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
The intraspecies uncertainty factor (UFHH =10x) is used in the determination of the reference dose or reference concentration and accounts for the pharmacokinetic and pharmacodynamic heterogeneity within the human population. The Food Quality Protection Act of 1996 mandated the use of an additional uncertainty factor (UFHC =10x) to take into account potential pre- and postnatal toxicity and lack of completeness of the data with respect to exposure and toxicity to children. There is no conclusive experimental or theoretical justification to support or refute the magnitude of the UFHH and UFHC nor any conclusive evidence to suggest that a factor of 100 is needed to account for intrahuman variability. This study presents a new chemical-specific method for estimating the pharmacokinetic (PK) component of the interspecies uncertainty factor (UFHH-PK and UFHC-PK) for volatile organic compounds (VOCs), The approach utilizes validated physiological-based pharmacokinetic (PBPK) models and simplified physiological-model-based algebraic equations to translate ambient exposure concentration to tissue dose in adults and children the ratio of which is the UFHH-PK and UFHC-PK The results suggest that: (1) the UFHH-PK and UFHC-PK are chemical specific; (ii) for the chemicals used in this study there is no significant difference between UFHH-PK and UFHC-PK; (iii) the magnitude of UFHH-PK and UFHC-PK varies between 0.033 and 2.85 with respect to tissue and blood concentrations; (iv) the body weight, the rate of ventilation, the fraction of cardiac output flowing to the liver, the blood:air partition coefficient, and the hepatic extraction ratio are the only parameters that play a critical role in the variability of tissue and blood doses within species; and (v) the magnitude of the UFHH-PK and UFHC-PK obtained with the simplified steady-state equations is essentially the same with that obtained with PBPK models. Overall, this study suggests that no adult-children differences in the parent chemical concentrations of the VOCs are likely to be observed during inhalation exposures. The physiological-model-based approaches used in the present study to estimate the UFHH-PK and UFHC-PK provide a scientific basis for their magnitude. They can replace the currently used empirical default approaches to provide chemical-specific UFHH-PK in future risk assessments. (C) 2001 Academic Press.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 23 条
[1]   PHARMACOKINETIC MODELING OF TRICHLOROETHYLENE AND TRICHLOROACETIC-ACID IN HUMANS [J].
ALLEN, BC ;
FISHER, JW .
RISK ANALYSIS, 1993, 13 (01) :71-86
[2]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING WITH DICHLOROMETHANE, ITS METABOLITE, CARBON-MONOXIDE, AND BLOOD CARBOXYHEMOGLOBIN IN RATS AND HUMANS [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
MACNAUGHTON, MG ;
REITZ, RH ;
NOLAN, RJ ;
MCKENNA, MJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1991, 108 (01) :14-27
[3]  
[Anonymous], EXP FACT HDB
[4]   PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELING OF THE LACTATING RAT AND NURSING PUP - A MULTIROUTE EXPOSURE MODEL FOR TRICHLOROETHYLENE AND ITS METABOLITE, TRICHLOROACETIC-ACID [J].
FISHER, JW ;
WHITTAKER, TA ;
TAYLOR, DH ;
CLEWELL, HJ ;
ANDERSEN, ME .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1990, 102 (03) :497-513
[5]  
International Life Sciences Institute, 1994, PHYS PAR VAL PBPK MO
[6]   Cytochrome p450-dependent metabolism of trichloroethylene: Interindividual differences in humans [J].
Lipscomb, JC ;
Garret, CM ;
Snawder, JE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 142 (02) :311-318
[7]  
National Academy of Sciences, 1977, DRINK WAT HLTH, V1
[8]   A PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR INHALED CARBON-TETRACHLORIDE [J].
PAUSTENBACH, DJ ;
CLEWELL, HJ ;
GARGAS, ML ;
ANDERSEN, ME .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 96 (02) :191-211
[9]   An approach for incorporating tissue composition data into physiologically based pharmacokinetic models [J].
Pelekis, M ;
Poulin, P ;
Krishnan, K .
TOXICOLOGY AND INDUSTRIAL HEALTH, 1995, 11 (05) :511-522
[10]  
PELEKIS M, 1997, TOXICOL METHOD, V7, P207